(Q38065495)

28 August 2017

1 reference

title

QTc prolongation by antiepileptic drugs and the risk of torsade de pointes in patients with epilepsy (English)

1 reference

28 August 2017

Ashley E Feldman

1 reference

28 August 2017

Barry E Gidal

series ordinal

1 reference

28 August 2017

publication date

4 December 2012

1 reference

28 August 2017

1 reference

28 August 2017

1 reference

28 August 2017

1 reference

28 August 2017

page(s)

421-426

1 reference

Too long or too short? New insights into abnormal cardiac repolarization in people with chronic epilepsy and its potential role in sudden unexpected death

28 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Sudden, unexpected death in epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Combined analysis of risk factors for SUDEP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Enhanced QT shortening and persistent tachycardia after generalized seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Time and frequency domain analyses of heart rate variability in patients with epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Arrhythmia, heart rate variability, and antiepileptic drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Pharmacogenetic aspects of drug-induced torsade de pointes: potential tool for improving clinical drug development and prescribing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Identification of a possible pathogenic link between congenital long QT syndrome and epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Post-mortem review and genetic analysis of sudden unexpected death in epilepsy (SUDEP) cases.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Lengthening of corrected QT during epileptic seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Electrocardiograph QT lengthening associated with epileptiform EEG discharges--a role in sudden unexplained death in epilepsy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Do antiepileptic drugs or generalized tonic-clonic seizure frequency increase SUDEP risk? A combined analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Iatrogenic QT Abnormalities and Fatal Arrhythmias: Mechanisms and Clinical Significance

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Drug-induced QT prolongation in women during the menstrual cycle

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Drug- and non-drug-associated QT interval prolongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Familial and acquired long qt syndrome and the cardiac rapid delayed rectifier potassium current

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Antiarrhythmic effects of increasing the daily intake of magnesium and potassium in patients with frequent ventricular arrhythmias. Magnesium in Cardiac Arrhythmias (MAGICA) Investigators

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Effect of sodium channel blockers on ST segment, QRS duration, and corrected QT interval in patients with Brugada syndrome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Phenytoin and phenobarbital inhibit human HERG potassium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Cardiac monitoring after phenytoin overdose

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Is primidone the drug of choice for epileptic patients with QT-prolongation? A comprehensive analysis of literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Primidone in the treatment of the long QT syndrome: QT shortening and ventricular arrhythmia suppression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Do antiepileptic drugs play a role in sudden unexpected death in epilepsy?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Cardiac function and antiepileptic drug treatment in the elderly: a comparison between lamotrigine and sustained-release carbamazepine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Lamotrigine does not prolong QTc in a thorough QT/QTc study in healthy subjects.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Increased risk of sudden unexpected death in epilepsy in females using lamotrigine: a nested, case-control study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

New SCN5A mutation in a SUDEP victim with idiopathic epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Pharmacokinetics and tolerability of single escalating doses of gabapentin enacarbil: a randomized-sequence, double-blind, placebo-controlled crossover study in healthy volunteers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Effects of the antiepileptic drugs lamotrigine, topiramate and gabapentin on hERG potassium currents.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

A placebo-controlled, random-assignment, parallel-group pilot study of adjunctive topiramate for patients with schizoaffective disorder, bipolar type.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Effect of levetiracetam on cardiac repolarization in healthy subjects: a single-dose, randomized, placebo- and active-controlled, four-way crossover study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Drug-induced QT-interval shortening following antiepileptic treatment with oral rufinamide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Intravenous lacosamide as short-term replacement for oral lacosamide in partial-onset seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Lacosamide in painful diabetic neuropathy: an 18-week double-blind placebo-controlled trial

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Lacosamide-induced second-degree atrioventricular block in a patient with partial epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Atrial flutter/atrial fibrillation associated with lacosamide for partial seizures

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

The mechanism of action of retigabine (ezogabine), a first-in-class K+ channel opener for the treatment of epilepsy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Safety and efficacy of ezogabine (retigabine) in adults with refractory partial-onset seizures: Interim results from two ongoing open-label studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Tolerability and safety of perampanel: two randomized dose-escalation studies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Assessment of potential drug interactions in patients with epilepsy: impact of age and sex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Depression and epilepsy: epidemiologic and neurobiologic perspectives that may explain their high comorbid occurrence.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

Antipsychotics and QT prolongation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YEBEH.2012.09.021

10.1016/J.YEBEH.2012.09.021

7 January 2021

Identifiers

DOI

1 reference

28 August 2017

1 reference